EXCEED THE SPACE PROVIDED. Hematopoiesis can be viewed as a patterning process in which the pluripotent stem cell proliferates and differentiates into the various distinct cellular lineages of the blood system. Hematopoietic development is controlled largely at the level of transcription. A central question in the study of hematopoiesis is how distinct blood cell fates are specified by combinations of transcription factors. The Ets-family transcription factor PU.1 is expressed specifically in the lymphoid (B cells, NK cells) and myeloid (macrophages, neutrophils) lineages of the immune system. Targeted mutation of the PU. 1 gene in mice reveals that it is essential for the development of B cells and macrophages, while development of T cells and neutrophils is aberrant or delayed. The activity of PU.1 on target genes is concentration dependent: macrophage development requires high concentrations of PU.1 while B cell development requires low concentrations. Genes encoding cytokine receptors are a major class of PU.1 target genes in developing hematopoietic progenitors. For example, PU.1 is essential for transcription of the Interleukin-7 receptor alpha gene (IL- 7R_) in developing lymphoid cells, and for the macrophage colony-stimulating factor receptor gene (M- CSFR, encoded by c-fms) in developing myeloid cells. Taken together, this evidence suggests that PU.1 plays a major role in cell fate decisions of stem cells to develop into the lymphoid or myeloid lineages. The focus of this grant proposal is to elucidate the function of PU. 1 in lympho-myeloid specification and in B cell differentiation. First, we will investigate whether graded levels of PU.1 regulate lymphoid versus myeloid cell fate decisions made by hematopoietic stem cells and/or multipotential progenitors. We will use both in vivo and in vitro approaches to address this problem. Second, we will utilize recently developed PU. 1-1-pro-B cell lines to investigate whether PU.1 is required for B cell differentiation in addition to being required for early events in B cell development. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI052175-03
Application #
6843796
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Nasseri, M Faraz
Project Start
2003-03-01
Project End
2008-02-28
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
3
Fiscal Year
2005
Total Cost
$302,753
Indirect Cost
Name
University of Cincinnati
Department
Genetics
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Stehling-Sun, Sandra; Dade, Jessica; Nutt, Stephen L et al. (2009) Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c. Nat Immunol 10:289-96
Zhu, Xiang; Schweitzer, Brock L; Romer, Eric J et al. (2008) Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling. Eur J Immunol 38:2587-99
Kamath, M B; Houston, I B; Janovski, A J et al. (2008) Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity. Leukemia 22:1214-25
DeKoter, Rodney P; Kamath, Meghana B; Houston, Isaac B (2007) Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models. Blood Cells Mol Dis 39:316-20
Houston, Isaac B; Kamath, Meghana B; Schweitzer, Brock L et al. (2007) Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality. Exp Hematol 35:1056-68
Houston, Isaac B; Huang, Kelly J; Jennings, Serena R et al. (2007) PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner. Exp Hematol 35:374-384
DeKoter, Rodney P; Schweitzer, Brock L; Kamath, Meghana B et al. (2007) Regulation of the interleukin-7 receptor alpha promoter by the Ets transcription factors PU.1 and GA-binding protein in developing B cells. J Biol Chem 282:14194-204
Schweitzer, Brock L; Huang, Kelly J; Kamath, Meghana B et al. (2006) Spi-C has opposing effects to PU.1 on gene expression in progenitor B cells. J Immunol 177:2195-207
Schweitzer, Brock L; DeKoter, Rodney P (2004) Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines. J Immunol 172:144-54